BlackRock’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $715M | Buy |
|
|||||
|
2025
Q2 | $435M | Sell |
|
|||||
|
2025
Q1 | $492M | Sell |
|
|||||
|
2024
Q4 | $461M | Buy |
|
|||||
|
2024
Q3 | $310M | Buy |
|
|||||
|
2024
Q2 | $400M | Buy |
|
|||||
|
2024
Q1 | $323M | Sell |
|
|||||
|
2023
Q4 | $281M | Buy |
|
|||||
|
2023
Q3 | $151M | Sell |
|
|||||
|
2023
Q2 | $241M | Buy |
|
|||||
|
2023
Q1 | $231M | Sell |
|
|||||
|
2022
Q4 | $286M | Sell |
|
|||||
|
2022
Q3 | $65M | Buy |
|
|||||
|
2022
Q2 | $71.5M | Buy |
|
|||||
|
2022
Q1 | $93.9M | Buy |
|
|||||
|
2021
Q4 | $80.5M | Buy |
|
|||||
|
2021
Q3 | $73.1M | Buy |
|
|||||
|
2021
Q2 | $88.6M | Sell |
|
|||||
|
2021
Q1 | $112M | Buy |
|
|||||
|
2020
Q4 | $105M | Buy |
|
|||||
|
2020
Q3 | $78.1M | Sell |
|
|||||
|
2020
Q2 | $76.9M | Buy |
|
|||||
|
2020
Q1 | $42M | Buy |
|
|||||
|
2019
Q4 | $52.8M | Buy |
|
|||||
|
2019
Q3 | $49.8M | Buy |
|
|||||
|
2019
Q2 | $58.9M | Buy |
|
|||||
|
2019
Q1 | $65.5M | Sell |
|
|||||
|
2018
Q4 | $60.1M | Sell |
|
|||||
|
2018
Q3 | $123M | Buy |
|
|||||
|
2018
Q2 | $137M | Buy |
|
|||||
|
2018
Q1 | $37.3M | Buy |
|
|||||
|
2017
Q4 | $19.2M | Buy |
|
|||||
|
2017
Q3 | $8.27M | Buy |
|
|||||
|
2017
Q2 | $2.84M | Buy |
|
|||||
|
2017
Q1 | $191K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $0 | Hold |
|
|||||
|
2015
Q4 | $1K | Hold |
|
|||||
|
2015
Q3 | $3K | Hold |
|
|||||
|
2015
Q2 | $3K | Sell |
|
|||||
|
2015
Q1 | $4K | Hold |
|
|||||
|
2014
Q4 | $5K | Hold |
|
|||||
|
2014
Q3 | $6K | Buy |
|
|||||
|
2014
Q2 | $6K | Hold |
|
|||||
|
2014
Q1 | $6K | Hold |
|
|||||
|
2013
Q4 | $7K | Buy |
|
|||||
|
2013
Q3 | $6K | Hold |
|
|||||
|
2013
Q2 | $5K | Buy |
|